Search

Displaying results 281 to 290 of 596.

News

Spin-off project Myxobiotics gains support from new incubator INCATE

First preclinical studies support cystobactamids as rapidly bactericidal, resistance-breaking drugs, which could become a powerful tool in fighting hospital-acquired and ventilator-associated pneumonia and bloodstream infections caused by resistant strains of…

04.02.2022
News

Moonlighting protein makes a hospital germ harmful

In our interview, Wulf Blankenfeldt explains what makes the Pseudomonas aeruginosa bacterium so dangerous, why he has never lost interest in the function of PqsE for over two decades - and how he was able to report the moonlighting of this protein. Professor…

14.12.2022
News

Three HZI scientists are among the most cited in their research fields

Prof Alice McHardy heads the department “Computational Biology of Infection Research” at BRICS (Braunschweig Integrated Centre of Systems Biology), a joint facility of the HZI and the Technische Universität Braunschweig. With the help of computational methods, she…

25.11.2022
News

Honorary Doctorate for Dirk Heinz

The Helmholtz Institute for RNA-based Infection Research (HIRI) , founded in Würzburg in 2017, pursues an innovative approach: It links research on ribonucleic acids (RNA) with infection biology. HIRI is a site of the Braunschweig Helmholtz Centre for Infection Research…

08.11.2022
News

SORMAS is finalist for Zayed Sustainability Prize 2023

The Zayed Sustainability Prize promotes small and medium-sized enterprises as well as nonprofit organizations and schools for sustainable achievements in the categories of health, nutrition, energy, water and secondary schools. The SORMAS open-source digital platform…

07.11.2022
News

Six Teams receive 1.5 Million Euros each for the development of new antiviral agents

Since the COVID 19 pandemic, we know: Viruses are a threat to human health worldwide. Despite the considerable success of vaccines, antiviral drugs are also needed to help sufferers. For many viral diseases there are still no effective drugs or therapeutic treatments.…

26.10.2022
News

Fusobacteria and Cancer

More than 4,500 species of bacteria colonize humans. Although their importance for well-being and health as well as for diseases is increasingly appreciated, the underlying molecular mechanisms are still largely unknown. This also applies to Fusobacteria: They are an…

03.11.2022
News

When the skin aches

It was already known that in both psoriasis and neurodermatitis, T-cells of the immune system migrate from the blood into the skin and drive the inflammation there. Detailed examination of T-cells in blood and skin now led to evidence that in atopic dermatitis they…

13.10.2022
News

GO-Bio initial funding for two natural product projects at the HZI

Basidiomycota produce a wide variety of secondary metabolites, some of which are already used clinically as antibiotics and anticancer drugs, and industrially as dietary supplements. Other secondary metabolites from this division of fungi appear promising for the…

28.09.2022
News

Up to 18 Million Euros for One Health-Region Vorpommern

The One Health-Region Vorpommern shall focus on health in all dimensions of human activity and consider the knock-on effects of all decisions made by politics, agriculture, conservation or tourism on health. In order to attain this goal, individual workshop projects…

19.09.2022